Birth cohort effects underlying the increasing testicular cancer incidence in Canada

Canadian Journal of Public Health

Volumn 90, Issue 3, 1999, Pages 176-180

  Liu, Shiliang ^a,b   Wen, Shi Wu ^a   Mao, Yang ^b   Mery, Les ^b   Rouleau, Jocelyn ^a  

^a Lab Center for Disease Control   (Canada)

^b LAB CENTRE FOR DISEASE CONTROL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; CANADA; CANCER INCIDENCE; CANCER RISK; CANCER STATISTICS; COHORT ANALYSIS; GROUPS BY AGE; HUMAN; MAJOR CLINICAL STUDY; MALE; STATISTICAL MODEL; TESTIS CANCER;

EID: 0033035681     PISSN: 00084263     EISSN: None     Source Type: Journal    
DOI: 10.1007/bf03404502     Document Type: Article

References (18)

1. National Cancer Institute of Canada (NCIC). Canadian Cancer Statistics 1997. Toronto: NCIC, 1997; 15-39.
2. Bergström R, Adami H-O, Möhner M, et al. Increase in testicular cancer incidence in six European countries: A birth cohort phenomenon. J Natl Cancer Inst 1996;88:727-33.
3. Zheng T, Holford TR, Ma Z, et al. Continuing increase in incidence of germ-cell testis cancer in young adults: Experience from Connecticut, USA, 1935-1992. Int J Cancer 1996;65:723-29.
4. Wanderås EH, Tretli S, Fosså SD. Trends in incidence of testicular cancer in Norway 1955-1992. Eur J Cancer 1995;31A:2044-48.
5. Møller H, Jørgenen N, Forman D. Trends in incidence of testicular cancer in boys and adolescent men. Int J Cancer 1995;61:761-64.
6. Brown LM, Pottern LM, Hoover RN, et al. Testicular cancer in the United States: Trends in incidence and mortality. Int J Epidemiol 1996;15:164-70.
7. Adami H-O, Bergström R, Möhner M, et al. Testicular cancer in nine Northern European countries. Int J Cancer 1994;59:33-38.
8. Band PR, Gaudette L, Hill GB, et al. The making of the Canadian cancer registry: Cancer incidence in Canada and its regions, 1969 to 1988. Ottawa: Canadian Council of Cancer Registries, 1993;16-21.
9. Le ND, Marrett LD, Robson DL, et al. Canadian Cancer Incidence Atlas, Vol. 1. Ottawa: Health Canada, 1995;20-24.
10. Horwich A, Malcolm DM, Hendry WF. Testicular tumours, In: Peckham M, Pinedo H, Veronesi U (Eds.), Oxford Textbook of Oncology Vol. 2, Oxford: Oxford University Press, 1995;1407-14.
11. Clayton D, Schifflers E. Models for temporal variation in cancer rates, I: Age-period and Age-cohort models. Stat Med 1987;6:449-67.
12. Clayton D, Schifflers E. Models for temporal variation in cancer rates, II: Age-period-cohort models. Stat Med 1987;6:469-81.
13. SAS Institute Inc., SAS Technical Report P-243, SAS/STAT Software: The GENMOD Procedure, Release 6.09, Cary, NC: SAS Institute Inc., 1993; 1-47.
14. Holford TR. Understanding the effects of age, period, and cohort on incidence and mortality rates. Annu Rev Public Health 1991;12:425-57.
15. Brown LM, Pottern LM, Hoover RN. Prenatal and perinatal risk factors for testicular cancer. Cancer Res 1986;46:4812-16.
16. Depue RH, Pike MC, Henderson BE. Estrogen exposure during gestation and risk of testicular cancer. J Natl Cancer Inst 1983;71:1151-55.
17. Gershman ST, Stolley PD. A case-control study of testicular cancer using Connecticut tumour registry data. Int J Epidemiol 1988;17:738-42.
18. Akre O, Ekbom A, Hsieh CC, et al. Testicular nonseminoma and seminoma in relation to perinatal characteristics. J Natl Cancer Inst 1996;88:883-89.